230950 Sigma-AldrichCiglitazone - CAS 74772-77-3 - Calbiochem
A potent thiazolinedione (TDZ) type anti-hyperglycemic agent and a selective PPARγ agonist (EC₅₀ = 3 µM).
More>> A potent thiazolinedione (TDZ) type anti-hyperglycemic agent and a selective PPARγ agonist (EC₅₀ = 3 µM). Less<<Synonyms: (±)-5-[4-(1-Methylcyclohexylmethoxy)benzyl]thiazolidine-2,4-dione, PPAR Agonist II, PPARγ Agonist I
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| CAS # | Empirical Formula |
|---|---|
| 74772-77-3 | C₁₈H₂₃NO₃S |
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 230950-5MG |
|
Plastic ampoule | 5 mg |
|
— |
| Product Information | |
|---|---|
| CAS number | 74772-77-3 |
| ATP Competitive | N |
| Form | White to tan solid |
| Hill Formula | C₁₈H₂₃NO₃S |
| Chemical formula | C₁₈H₂₃NO₃S |
| Reversible | N |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | Selective PPARγ agonist |
| Primary Target IC<sub>50</sub> | EC50 = 3 µM as PPARγ agonist |
| Purity | ≥98% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS | |
|---|---|
| RTECS | XJ5813700 |
| Safety Information | |
|---|---|
| R Phrase | R: 20/21/22 Harmful by inhalation, in contact with skin and if swallowed. |
| S Phrase | S: 36 Wear suitable protective clothing. |
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 230950-5MG | 04055977218312 |
Documentation
Ciglitazone - CAS 74772-77-3 - Calbiochem SDS
| Title |
|---|
Ciglitazone - CAS 74772-77-3 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 230950 |
References
| Reference overview |
|---|
| Jha, R.J. 1999. Clin. Exp. Hypertens. 21, 157. Xin, X., et al. 1999. J. Biol. Chem. 274, 9116. Lohrke, B., et al. 1998. J. Endocrinol. 159, 429. Willson, T.M., et al. 1996. J. Med. Chem. 39, 665. Cantello, B.C., et al. 1994. J. Med. Chem. 37, 3977. |



